polypil tz vernon drug medicin term polypil coin refer medic combin activ ingredi controversi articl bmj wald law propos concept polypil combin medic market decad order reduc cardiovascular diseas wald law innov analyt approach combin numer high qualiti metaanalys individu impact medic produc estim combin propos polypil morbid mortal polypil idea physic pill increas adher complianc reduc number pill person novel methodolog approach sens numer metaanalysi metaanalys estim combin impact medic intervent articl written propos sort polypil methodolog wald law promis polypil diabet prediabet kuehn polypil slash diabet risk jama wald law polypil strategi reduc cardiovascular diseas paper strategi reduc cardiovascular diseas publish british medic journal june wald law postul combin well cheap medic pill polypil effect treatment cardiovascular diseas present statist model suggest widespread polypil reduc mortal heart diseas stroke treatment cheap side effect recipi base data trial relat individu compon actual patient real benefit combin medic compar infer benefit calcul overwhelm evid favor polypil individu compon concept well recognis reduc blood pressur cholesterol low dose aspirin will help prevent heart diseas stroke test wald law polypil recommend addit polypil current india gp current prescrib compon polypil separ herhi patient ingredi polypil patent polypil cheap estim bmj rapid respons pound year financi incent pharmaceut compani pay high cost clinic trial natur larg insur nation healthcar system consider financi incent pay trial wald law unusu novel perspect age pill medic manag issu irrespect individu risk idea reduc blood pressur cholesterol patient popul will benefit basic polypil default medic peopl compar risk current individu cardiovascular risk calcul base year longitudin studi go popul framingham massachusett framingham heart studi polypil take popul base approach manag concept normal treatment threshold relev popul base approach diseas controltradit approach treat risk threshold reach paradox individu reach tradit threshold benefit will accru reduct blood pressur cholesterol slide scale risk concept abnorm side correspond high risk requir treatment normal side low risk requir treatment scrutini doctor will treat popul risk individu risk factor threshold current mainstream practic polypil averag blood pressur cholesterol level popul fall reduc popul risk polypil blood pressur medic low dose diuret bendroflumethiazid betablock atenolol ace inhibitor enalapril combin statin simvastatin aspirin dose folic acid folic acid reduc level homocystein blood risk factor heart diseas plan coordin intern forum discuss concept polypil polypil diabet syndrom diabet type ii diabet major morbid mortal diabet contribut cardiovascular risk ingredi wald law origin polypil advis patient diabet exampl betablock lead weight gain thiazid diuret polypil diabet includ statin reduc ldl cholesterol antiinflamatori properti ace inhibitor blood pressur control protect kidney aspirin anti platelet antiinflamatori properti metformin excel medic diabet associ weight loss peopl overweight diabet know addit peopl pre diabet benefit activ intervent peopl diabet prediabet high cholesterol high blood pressur overweight consid metabol syndrom benefit diabet polypil polypil strategi peopl normal bodi mass waist circumfer will wald law polypil obes overweight will diabet syndrom polypil cost effect wald law analysi correct major cost save product gain polypil approach diabet syndrom polypil estim save billion dollar importantli tremend human cost devast underappreci chronic diseas reduc person stroke ruin qualiti life place major burden carer kidney failur dialysi common endstag diabet devast health care system major insur kaiser permanent well financi human level fulli test introduc polypil sourc resist medic expertis simplic treatment polypil strategi work larg percentag patient popul threaten expert specialist stand lose financi doubt expert delight human benefit endors despit person financi hardship polypil simpl offtherack default treatment reduc sens control exercis expertis prescrib individu tailor medic regimen individu tailor approach expens difficult time consum access lifestyl modif punish sinner larg cohort health profession advoc lifestyl modif true smoke exercis hour day eat healthi low fat diet time dramat reduc cardiovascular risk peopl realiti find difficult unpleas invas intrus adher realiti achiev sustain gain increas evid individu healthli lifestyl medic statin reduc cardiovascular risk doubt best remind patient benefit lifestyl modif encourag pursu justifi delay highli benefici medic polypil practic peopl will sustain suffici lifestyl modif will benefit medic contain polypil sens overli strong devot lifestyl modif approach impli sinner unabl unwil dramat alter lifestyl habit expect suffer noncompli appropri deal fellow human be flaw weak deserv effect prevent care natur individu prefer lifestyl modif approach encourag remind peopl succeed effect medic treatment cardiovascular diseas diabet asymptomat substanti irrevers damag dogmat lifestyl modif approach danger drive patient treatment satir wald law approach gener substanti controversi critic origin contribut regard form satir articl well written propos tongu cheek mixtur healthi food type author refer polym refer wald law strategi reduc cardiovascular diseas british medic journal june kuehn polypil slash diabet risk jama test start pill lengthen million live tablet aim cut heart attack stroke risk fourinon drug sold month sarah boseley health editor guardian monday septemb